NewsBenzingaFDA, HRR 유전자 변이 전이성 안드로겐 경로 조절 미경험 또는 민감성 전립선암 치료제 타라조파립과 엔잘루타마이드 병용 요법 승인 FDA, HRR 유전자 변이 전이성 안드로겐 경로 조절 미경험 또는 민감성 전립선암 치료제 타라조파립과 엔잘루타마이드 병용 요법 승인 Benzinga 2026.10.26 16:46 (GMT+0) Open on Benzinga Other news A whale accumulates 238,400 LINK from Binance in two days, worth about $2.2 million Huobi HTX to Open Spot Trading for SOXS, KORU and SNXX on November 17 Duan Yongping Trims Nvidia and Apple in Q3, Exits Alibaba and CRCL, Opens New SpaceX Stake Ethereum Glamsterdam upgrade testing finds bug: some internal payments skipped while transaction succeeds US Says Justice Leads Megaspeed AI-Chip Investigation Soluna Holdings, Inc. (SLNH) Q3 2026 Earnings Call Transcript
Ethereum Glamsterdam upgrade testing finds bug: some internal payments skipped while transaction succeeds